Pulmonary sporotrichosis treated with itraconazole

Chest. 1993 Jan;103(1):313-4. doi: 10.1378/chest.103.1.313.

Abstract

A 62-year-old woman had chronic cavitary pulmonary sporotrichosis refractory to medical management over an 8-year period. She was treated with oral itraconazole and had an apparent microbiologic and clinical response; however, the patient succumbed to progressive pulmonary hypertension. The early use of oral itraconazole for treatment of pulmonary sporotrichosis is advocated.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Female
  • Humans
  • Itraconazole
  • Ketoconazole / administration & dosage
  • Ketoconazole / analogs & derivatives*
  • Ketoconazole / therapeutic use
  • Lung Diseases, Fungal / drug therapy*
  • Middle Aged
  • Potassium Iodide / therapeutic use
  • Sporotrichosis / drug therapy*

Substances

  • Antifungal Agents
  • Potassium Iodide
  • Itraconazole
  • Amphotericin B
  • Ketoconazole